Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
about
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and ApplicationReview: Application of Nanoparticles in Urothelial Cancer of the Urinary BladderLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesImproving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies.Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats.Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterineLipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity.Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon.Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.Novel lecithin-integrated liquid crystalline nanogels for enhanced cutaneous targeting of terconazole: development, in vitro and in vivo studies.Nanotechnology-based drug delivery systems and herbal medicines: a review.Nanostructured lipid carriers: versatile oral delivery vehicle.Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.Nanostructured lipid carriers system: recent advances in drug delivery.Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.Solid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.Potential bioavailability enhancement of bioactive compounds using food-grade engineered nanomaterials: a review of the existing evidence.Nanostructured lipid carriers and their current application in targeted drug delivery.A perspective overview on lipospheres as lipid carrier systems.Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.Advances in lipid-based drug delivery: enhancing efficiency for hydrophobic drugs.Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.Utilization of nanoemulsions to enhance bioactivity of pharmaceuticals, supplements, and nutraceuticals: Nanoemulsion delivery systems and nanoemulsion excipient systems.Montelukast medicines of today and tomorrow: from molecular pharmaceutics to technological formulations.Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects.Nanoparticle-based targeted gene therapy for lung cancer.Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model.Caveolar uptake and endothelial-protective effects of nanostructured lipid carriers in acid aspiration murine acute lung injury.Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation.Stability of paclitaxel-loaded solid lipid nanoparticles in the presence of 2-hydoxypropyl-β-cyclodextrin.
P2860
Q26778603-EE5B6307-063E-4A90-BBF3-F9E98F31C152Q28386921-0E48C394-38F5-4D45-B080-1EE44089F12EQ30366990-F71AC744-31C4-4769-A2E8-F73A126C1F57Q33683206-D7D5AC37-E4DA-4977-9F61-174FF2D6C10DQ33710442-6775D50B-0D6B-409F-BD1E-298E1D797466Q35122206-3F40F246-7528-4951-BFA1-519585CFFBB8Q35928366-09204C75-243F-49FB-BA90-E5421629D4A0Q36191349-0D9108E1-6091-49D7-8BFE-EE7F5D0633ABQ36208560-D67CDC8F-C7F5-4558-8FFF-B030730FA12CQ37134733-FD14E197-CFFD-47BC-A6BB-F67CB2CEB5FBQ37158892-C70A1EDF-05E2-491B-AA4D-542F18128DDAQ37261858-DEE0DE92-F422-459A-B3F4-F1AA596BDD98Q37280515-08EBE497-8ECB-4CD4-9AD3-A81ADEE93202Q37381451-4F477E29-A6D2-47E2-A6C6-741A627CEA30Q37391136-63D8725B-805A-4E44-A946-7B888B65D71BQ37474497-CD42887A-4B68-4271-B90F-F6DF5A76F08DQ37646827-A5A136BC-5E11-48F5-BFA5-7A4E4A08E378Q37947952-CB28040E-7AE8-4FCC-A22B-A4A4CD673418Q38038902-A5B3367A-42DA-4AB5-BA0B-67E01E85628FQ38115195-BB7F7CF8-4C9C-493D-9695-BE655E8EDC93Q38160303-6FCDCC5C-F999-4278-86A4-3AC243F21468Q38199540-DBE0BBBF-2EE3-430D-ACAD-9E516B23FE55Q38206137-4F28A4D6-01F8-4219-9B1D-78F6B9A257B5Q38210565-875FB189-E547-4DE5-AC7A-F157A35260DFQ38271617-2EB3185C-F786-4BC5-94A1-17D08572CA3AQ38286203-F62F76D5-8822-4262-BF0F-7DE71CDCA18CQ38406190-95F3FE87-7C79-4E45-94D3-1D03B98BA865Q38550745-3F9EA682-E3AA-417B-8FAC-A1147873FD09Q38552573-7B2E9655-CB3E-4BDE-9D1F-1BF21FFCFBC9Q38777505-69D14B87-58B3-4940-B308-F72E20212B80Q38787365-EF340FDA-334D-4E43-9126-2DAD741DCFFAQ38836879-75525B28-AA3F-4674-B88E-E132D0516659Q38854207-2A466F03-0AF1-4CE6-BD0D-5708D116C810Q38981743-B6275671-60FB-41FF-829C-31FB64969F6DQ39049314-30DB5757-3129-455B-9020-FDDBF5ECD49FQ39062936-5F1B4F76-E5F3-429B-B904-D73593AEB445Q39172372-A427E201-643D-4063-A59B-9DFFD2FF77AEQ39518383-EC94A5C1-5218-4DE0-A09C-015DF2A034BCQ39609219-8C8728E1-D3A9-43AF-AF98-F56655A3EF49Q39794160-27AA2279-762D-4644-8C46-55A28B5C79CA
P2860
Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@ast
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@en
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@nl
type
label
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@ast
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@en
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@nl
prefLabel
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@ast
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@en
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@nl
P2860
P1433
P1476
Recent advances in lipid nanop ...... matrix for oral drug delivery.
@en
P2093
Anumita Chaudhury
Surajit Das
P2860
P2888
P356
10.1208/S12249-010-9563-0
P407
P577
2010-12-21T00:00:00Z
P5875
P6179
1018551083